Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II
- 1 October 1989
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 28 (20) , 8154-8160
- https://doi.org/10.1021/bi00446a029
Abstract
Note: In lieu of an abstract, this is the article's first page.This publication has 10 references indexed in Scilit:
- Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro.Proceedings of the National Academy of Sciences, 1988
- In vitro transcription of eukaryotic genes is affected differently by the degree of DNA supercoiling.Proceedings of the National Academy of Sciences, 1988
- Expression of the Drosophila type II topoisomerase is developmentally regulatedBiochemistry, 1988
- Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.Journal of Biological Chemistry, 1987
- PROLIFERATION-DEPENDENT TOPOISOMERASE-II CONTENT AS A DETERMINANT OF ANTINEOPLASTIC DRUG-ACTION IN HUMAN, MOUSE, AND CHINESE-HAMSTER OVARY CELLS1987
- Topoisomerase II: A specific marker for cell proliferation.The Journal of cell biology, 1986
- DNA topoisomerase II is required at the time of mitosis in yeastCell, 1985
- Localization of topoisomerase II in mitotic chromosomes.The Journal of cell biology, 1985
- Topoisomerase II is a structural component of mitotic chromosome scaffolds.The Journal of cell biology, 1985
- ROLE OF TOPOISOMERASE-II IN MEDIATING EPIPODOPHYLLOTOXIN-INDUCED DNA CLEAVAGE1984